|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | FDG-PET for management of cervical and ovarian cancer显示文摘 | Havrilesky LJ Kulasingam SL Matchar DB | 2005 | Gynecol Oncol2005，97，1： | 1 |
| 2 | Evaluation of human papillomavirus testing in primary screening for cervical abnormalities : comparison of sensitivity, specificity, and frequency of referral 显示文摘 | Kulasingam SL Hughes JP Kiviat NB | 2002 | JAMA2002，288，14： | 1 |
| 3 | Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS)显示文摘 | Kulasingam SL Kim JJ Lawrence WF | 2001 | J Natl Cancer lnst2001，98，2： | 1 |
| 4 | Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral 显示文摘 | Kulasingam SL Hughes JP Kiviat NB | 2002 | JAMA2002，288，14： | 1 |
| 5 | Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study(ALTS)显示文摘 | Kulasingam SL Kim JJ Lawrence WF | | 0，，： | 1 |
| 6 | Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a costeffectiveness analysis 显示文摘 | Kulasingam SL Rajan R St Pierre Y | 2009 | BMC Med2009，9，7： | 1 |
| 7 | FDG-PET for management of cervical and ovarian cancer显示文摘 | Kulasingam SL Matchar DB | 2005 | Gynecolvoncol2005，97，1： | 1 |
| 8 | Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral显示文摘 | Kulasingam SL Hughes JP Kiviat NB | 2002 | JAMA2002，288，14： | 1 |
| 9 | FDG-PET for management of cervical and ovarian cancer 显示文摘 | Havrilesky LJ Kulasingam SL Matchar DB | 2005 | Gynecol Oncol2005，97，1： | 1 |
| 10 | Evaluation of human papillomavirus testing in primary screening for cervical abnormalities-comparison of sensitivity, specificity, and frequency of referral显示文摘 | Kulasingam SL Hughes JP Kiviat NB | 2002 | JAMA2002，288，： | 1 |
| 11 | Meta-analysis:the detection of pancreatic malignancy with positron emission tomography显示文摘 | Orlando LA Kulasingam SL Matchar DB | | 0，，： | 1 |
| 12 | Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998-2007 显示文摘 | Nelson EJ Hughes J Kulasingam SL | 2010 | Spat Spatiotemporal Epi- demiol2010，9，： | 1 |
| 13 | Potential health and economic impact of adding a human papillomavirus vaccine to screening programs 显示文摘 | Kulasingam SL Myers ER | 2003 | JAMA2003，290，： | 1 |
| 14 | Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral 显示文摘 | Kulasingam SL Hughes JP Kiviat NB | 2002 | JAMA2002，288，14： | 1 |
| 15 | Cost-effec-tiveness analysis based on the atypical squamous cells of deter-mined significance/low-grade squamous intraepithe-lial lesion triage study(ALTS)显示文摘 | Kulasingam SL Kim JJ Lawrence WF | 2001 | J Natl Cancer Inst2001，98，2： | 1 |
| 16 | Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral显示文摘 | Kulasingam SL Hughes JP Kiviat NB | 2002 | JAMA2002，288，14： | 1 |
| 17 | FDG-PET for management of cervical and ovarian cancer显示文摘 | Havrileshu LJ Kulasingam SL Marchar DB | 2005 | Gynecol Oncol2005，97，1： | 1 |
| 18 | Modeling preventative strategies against human papillomavirus-related disease in devel- oped countries显示文摘 | Canfell K Chesson H Kulasingam SL et ol | 2012 | Vaccine2012，30，5： | 1 |
| 19 | Modeling preventative strategies against human papillomavirus-related dis- ease in developed countries 显示文摘 | CANFELL K CHESSON H KULASINGAM SL | 2012 | Vaccine2012，30，5： | 1 |
| 20 | FDG PET for management of cervical and ovarian cancer显示文摘 | Kulasingam SL Matchar DB | 2005 | Gynecol Oncol2005，97，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员